Granulomatous inflammation in cartilage-hair hypoplasia: Risks and benefits of anti-TNF-α mAbs

Journal of Allergy and Clinical Immunology

Volumn 128, Issue 4, 2011, Pages 847-853

  Moshous, Despina ^a   Meyts, Isabelle ^a   Fraitag, Sylvie ^a   Janssen, Carl E I ^b   Debré, Marianne ^a   Suarez, Felipe ^a,c   Toelen, Jaan ^a   De Boeck, Kris ^a   Roskams, Tania ^c   Deschildre, Antoine ^d   Picard, Capucine ^a,d,f   Bodemer, Christine ^a,e   Wouters, Carine ^a   Fischer, Alain ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f IMAGINE INSTITUTE   (France)

Author keywords

anti TNF mAb therapy; Cartilage hair hypoplasia; granulomatous inflammation; infliximab; primary immunodeficiency; progressive multifocal leukoencephalopathy

Indexed keywords

ALEMTUZUMAB; ALPHA2A INTERFERON; CIDOFOVIR; CYCLOSPORIN; CYTARABINE; FLUDARABINE; HYDROXYCHLOROQUINE SULFATE; IMMUNOGLOBULIN; INFLIXIMAB; LEFLUNOMIDE; MELPHALAN; MIRTAZAPINE; STEROID; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CARTILAGE HAIR HYPOPLASIA; CARTILAGE HYPOPLASIA; CHILD; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CUSHINGOID SYNDROME; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; GRAFT VERSUS HOST REACTION; GRANULOMATOUS INFLAMMATION; HAIR DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; JC VIRUS; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SCHOOL CHILD; SPINE DISEASE; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL; CHILD; CHILD, PRESCHOOL; DERMATITIS; FEMALE; GRANULOMA; HAIR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIRSCHSPRUNG DISEASE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFLAMMATION; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; OSTEOCHONDRODYSPLASIAS; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80053572452     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.05.024     Document Type: Article

References (53)

1. V.A. McKusick, R. Eldridge, J.A. Hostetler, U. Ruangwit, and J.A. Egeland Dwarfism in the Amish. Ii. Cartilage-hair hypoplasia Bull Johns Hopkins Hosp 116 1965 285 326
2. O. Makitie, T. Sulisalo, A. de la Chapelle, and I. Kaitila Cartilage-hair hypoplasia J Med Genet 32 1995 39 43
3. O. Makitie, E. Pukkala, L. Teppo, and I. Kaitila Increased incidence of cancer in patients with cartilage-hair hypoplasia J Pediatr 134 1999 315 318 (Pubitemid 30417640)
4. M. Taskinen, A. Ranki, E. Pukkala, L. Jeskanen, I. Kaitila, and O. Makitie Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma Am J Med Genet A 146A 2008 2370 2375
5. C.T. Thiel, D. Horn, B. Zabel, A.B. Ekici, K. Salinas, and E. Gebhart Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator Am J Hum Genet 77 2005 795 806 (Pubitemid 41513281)
6. C.T. Thiel, G. Mortier, I. Kaitila, A. Reis, and A. Rauch Type and level of RMRP functional impairment predicts phenotype in the cartilage hair hypoplasia-anauxetic dysplasia spectrum Am J Hum Genet 81 2007 519 529 (Pubitemid 47330210)
7. N.L. Rider, D.H. Morton, E. Puffenberger, C.L. Hendrickson, D.L. Robinson, and K.A. Strauss Immunologic and clinical features of 25 Amish patients with RMRP 70 A→G cartilage hair hypoplasia Clin Immunol 131 2009 119 128
8. L.D. Notarangelo, C.M. Roifman, and S. Giliani Cartilage-hair hypoplasia: molecular basis and heterogeneity of the immunological phenotype Curr Opin Allergy Clin Immunol 8 2008 534 539
9. O. Makitie, and I. Kaitila Cartilage-hair hypoplasia - clinical manifestations in 108 Finnish patients Eur J Pediatr 152 1993 211 217 (Pubitemid 23053247)
10. O. Makitie, E. Pukkala, and I. Kaitila Increased mortality in cartilage-hair hypoplasia Arch Dis Child 84 2001 65 67 (Pubitemid 32060141)
11. F. Berthet, C.A. Siegrist, H. Ozsahin, P. Tuchschmid, G. Eich, and A. Superti-Furga Bone marrow transplantation in cartilage-hair hypoplasia: correction of the immunodeficiency but not of the chondrodysplasia Eur J Pediatr 155 1996 286 290 (Pubitemid 26096393)
12. C.I. Gallimore, D. Lewis, C. Taylor, A. Cant, A. Gennery, and J.J. Gray Chronic excretion of a norovirus in a child with cartilage hair hypoplasia (CHH) J Clin Virol 30 2004 196 204 (Pubitemid 38582028)
13. R. Guggenheim, R. Somech, E. Grunebaum, A. Atkinson, and C.M. Roifman Bone marrow transplantation for cartilage-hair-hypoplasia Bone Marrow Transplant 38 2006 751 756 (Pubitemid 44756445)
14. V. Bordon, A.R. Gennery, M.A. Slatter, E. Vandecruys, G. Laureys, and P. Veys Clinical and immunological outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation Blood 116 2010 27 35
15. J.M. van den Berg, E. van Koppen, A. Ahlin, B.H. Belohradsky, E. Bernatowska, and L. Corbeel Chronic granulomatous disease: the European experience PLoS One 4 2009 e5234
16. O. Ardeniz, and C. Cunningham-Rundles Granulomatous disease in common variable immunodeficiency Clin Immunol 133 2009 198 207
17. C. Cunningham-Rundles How I treat common variable immune deficiency Blood 116 2010 7 15
18. C. Schuetz, K. Huck, S. Gudowius, M. Megahed, O. Feyen, and B. Hubner An immunodeficiency disease with RAG mutations and granulomas N Engl J Med 358 2008 2030 2038 (Pubitemid 351656457)
19. G.W. Sewell, D.J. Marks, and A.W. Segal The immunopathogenesis of Crohn's disease: a three-stage model Curr Opin Immunol 21 2009 506 513
20. J.P. de Villartay, A. Lim, H. Al-Mousa, S. Dupont, J. Dechanet-Merville, and E. Coumau-Gatbois A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection J Clin Invest 115 2005 3291 3299 (Pubitemid 41567594)
21. E. Morelon, A. Dautry-Varsat, F. Le Deist, S. Hacein-Bay, A. Fischer, and G. de Saint Basile T-lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor gamma c chain in a severe combined immune deficiency X1 patient Blood 88 1996 1708 1717 (Pubitemid 26307066)
22. W.M. Comans-Bitter, R. de Groot, R. van den Beemd, H.J. Neijens, W.C. Hop, and K. Groeneveld Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations J Pediatr 130 1997 388 393 (Pubitemid 27492682)
23. EBMT/ESID guidelines for haematopoeitic stem cell transplantation for primary immunodeficiencies Available at: http://www.esid.org/bone-marrow- transplantation-ebmt-esid-guidelines-for-haematopoietic-stem-cell- transplantation-for-pi-350-0 Accessed June 15, 2011
24. J.L. Arbiser Genetic immunodeficiencies: cutaneous manifestations and recent progress J Am Acad Dermatol 33 1995 82 89
25. M. Fernandez-Ruiz, J.M. Guerra-Vales, C.F. Francisco-Javier, R.G. Yolanda, M.G. Miguel-Ingel, and G.C. Cristina Fever of unknown origin in a patient with common variable immunodeficiency associated with multisystemic granulomatous disease Intern Med 46 2007 1197 1202
26. Y. Morimoto, and J.M. Routes Granulomatous disease in common variable immunodeficiency Curr Allergy Asthma Rep 5 2005 370 375 (Pubitemid 41683980)
27. A. Torrelo, I.G. Mediero, and A. Zambrano Caseating cutaneous granulomas in a child with common variable immunodeficiency Pediatr Dermatol 12 1995 170 173
28. B.A. Drolet, B. Drolet, A. Zvulunov, R. Jacobsen, J. Troy, and N.B. Esterly Cutaneous granulomas as a presenting sign in ataxia-telangiectasia Dermatology 194 1997 273 275 (Pubitemid 27216043)
29. A.S. Paller, R.B. Massey, M.A. Curtis, J.M. Pelachyk, H.C. Dombrowski, and F.E. Leickly Cutaneous granulomatous lesions in patients with ataxia-telangiectasia J Pediatr 119 1991 917 922
30. M.G. Fleming, A.T. Gewurz, and R.W. Pearson Caseating cutaneous granulomas in a patient with X-linked infantile hypogammaglobulinemia J Am Acad Dermatol 24 1991 629 633
31. S.S. De Ravin, E.W. Cowen, K.A. Zarember, N.L. Whiting-Theobald, D.B. Kuhns, and N.G. Sandler Hypomorphic Rag mutations can cause destructive midline granulomatous disease Blood 116 2010 1263 1271
32. J. Rohr, U. Pannicke, M. Doring, A. Schmitt-Graeff, E. Wiech, and A. Busch Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency J Clin Immunol 30 2010 314 320
33. C.A. Vogel, E.J. Stratman, S.J. Reck, and J.J. Lund Chronic noninfectious necrotizing granulomas in a child with Nijmegen breakage syndrome Pediatr Dermatol 27 2010 285 289
34. J.E. Clarridge 3rd Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases Clin Microbiol Rev 17 2004 840 862
35. R. Whitley The new age of molecular diagnostics for microbial agents N Engl J Med 358 2008 988 989 (Pubitemid 351347097)
36. M. de Jager, W. Blokx, A. Warris, M. Bergers, M. Link, and C. Weemaes Immunohistochemical features of cutaneous granulomas in primary immunodeficiency disorders: a comparison with cutaneous sarcoidosis J Cutan Pathol 35 2008 467 472 (Pubitemid 351519416)
37. N.H. Ruddle Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) Curr Opin Immunol 4 1992 327 332
38. A.A. Kruglov, A. Kuchmiy, S.I. Grivennikov, A.V. Tumanov, D.V. Kuprash, and S.A. Nedospasov Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models Cytokine Growth Factor Rev 19 2008 231 244
39. V. Kindler, A.P. Sappino, G.E. Grau, P.F. Piguet, and P. Vassalli The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection Cell 56 1989 731 740 (Pubitemid 19082507)
40. P. Aukrust, E. Lien, A.K. Kristoffersen, F. Muller, C.J. Haug, and T. Espevik Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency - possible immunologic and clinical consequences Blood 87 1996 674 681 (Pubitemid 26030323)
41. C.G. Mullighan, G.C. Fanning, H.M. Chapel, and K.I. Welsh TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease J Immunol 159 1997 6236 6241 (Pubitemid 127471565)
42. A. Mitra, B. Pollock, J. Gooi, J.C. Darling, A. Boon, and J.A. Newton-Bishop Cutaneous granulomas associated with primary immunodeficiency disorders Br J Dermatol 153 2005 194 199 (Pubitemid 41044550)
43. L. Peyrin-Biroulet, P. Deltenre, N. de Suray, J. Branche, W.J. Sandborn, and J.F. Colombel Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials Clin Gastroenterol Hepatol 6 2008 644 653 (Pubitemid 351783447)
44. N.J. Sweiss, and L.L. Hushaw Biologic agents for rheumatoid arthritis: 2008 and beyond J Infus Nurs 32 suppl 2009 S4 S24
45. N. Milman, C.B. Andersen, A. Hansen, T. van Overeem Hansen, F.C. Nielsen, and H. Fledelius Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation APMIS 114 2006 912 919 (Pubitemid 44967328)
46. A. Thatayatikom, S. Thatayatikom, and A.J. White Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature Ann Allergy Asthma Immunol 95 2005 293 300 (Pubitemid 41376801)
47. A.Z. Hatab, and Z.K. Ballas Caseating granulomatous disease in common variable immunodeficiency treated with infliximab J Allergy Clin Immunol 116 2005 1161 1162 (Pubitemid 41571805)
48. J.H. Lin, M. Liebhaber, R.L. Roberts, Z. Dyer, and E.R. Stiehm Etanercept treatment of cutaneous granulomas in common variable immunodeficiency J Allergy Clin Immunol 117 2006 878 882
49. S. Paramothayan, and T. Lasserson Treatments for pulmonary sarcoidosis Respir Med 102 2008 1 9 (Pubitemid 350151832)
50. L. Marodi, and J.L. Casanova Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments J Allergy Clin Immunol 126 2010 910 917
51. A. Lavagna, M. Bergallo, M. Daperno, R. Sostegni, C. Costa, and R. Leto Infliximab and the risk of latent viruses reactivation in active Crohn's disease Inflamm Bowel Dis 13 2007 896 902 (Pubitemid 47203868)
52. A.M. Thielen, C. Barde, J.H. Saurat, and E. Laffitte Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists Dermatology 219 2009 59 62
53. D. Kumar, T.W. Bouldin, and R.G. Berger A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab Arthritis Rheum 62 2010 3191 3195